Objective: To determine the spectrum of severity and early diagnostic predictors of redback spider bites (Latrodectus hasselti ), and to examine the effect of intramuscular redback antivenom.
Design and setting: Prospective cohort study of calls to New South Wales, Queensland and Western Australian poisons information centres and presentations to Royal Prince Alfred Hospital and Royal Darwin Hospital emergency departments.
Patients: 68 people with definite redback spider bites in which the spider was immediately collected and expertly identified (1 February 1999 to 30 April 2002).
Interventions: Intramuscular redback spider antivenom in a smaller cohort of hospitalised patients.
Main outcome measures: Pain severity and duration, local effects and systemic envenomation (effects, prevalence, and persistence > 24 hours).
Results: The median duration of effects was 48 hours (interquartile range, 24–96 hours). Pain occurred after all bites and was severe in 42 (62%). Forty-five patients (66%) had pain lasting longer than 24 hours, and 22 (32%) were unable to sleep because of pain. Systemic effects occurred in 24 (35%). Increasing pain over one hour occurred in 37 cases (54%), and local/regional diaphoresis in 23 (34%); both these features were highly predictive of L. hasselti bites compared with bites of other spiders. One of six patients treated with intramuscular antivenom (17%) had no pain at 24 hours, compared with two of 17 untreated patients (12%) (difference, 5%; 95% CI, –36% to +64%; P = 0.95). There was no difference in duration of systemic effects with antivenom administration.
Conclusions: Most redback spider bites cause severe and persistent effects. Intramuscular antivenom appears to be less effective than previously thought and its use by this route needs review.
- 1. Bettini S, Maroli M. Venoms of Theridiidae, Genus Latrodectus. In: Bettini S, editor. Arthropod venoms. Berlin: Springer-Verlag, 1978; 149-189.
- 2. Stallybrass FC. Spider bites. Lancet 1969; 1: 572.
- 3. Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med 1992; 21: 782-787.
- 4. Isbister GK, Gray MR. A prospective study of 750 definite spider bites, with expert spider identification. QJM 2002; 95: 723-731.
- 5. Vetter RS, Visscher PK. Bites and stings of medically important venomous arthropods. Int J Dermatol 1998; 37: 481-496.
- 6. Isbister GK. Failure of intramuscular antivenom in redback spider envenomation. Emerg Med (Fremantle) 2002; 14: 436-439.
- 7. Nicholson GM, Graudins A. Spiders of medical importance in the Asia-Pacific: atracotoxin, latrotoxin and related spider neurotoxins. Clin Exp Pharmacol Physiol 2002; 29: 785-794.
- 8. White J. Envenoming and antivenom use in Australia. Toxicon 1998; 36: 1483-1492.
- 9. White J, Cardoso JL, Hui WF. Clinical toxicology of spider bites. In: Meier J, White J, editors. Handbook of clinical toxicology of animal venoms and poisons. Boca Raton, Fl: CRC Press, 1995; 259-330.
- 10. Jelinek GA, Banham NG, Dunjey SJ. Red-back spider-bites at Fremantle Hospital, 1982–1987. Med J Aust 1989; 150: 693-695.
- 11. White J. CSL antivenom handbook. 2nd edn. Melbourne: CSL Ltd, 2001.
- 12. Wiener S. Redback spider bite in Australia: an analysis of 167 cases. Med J Aust 1961; 2: 44-49.
- 13. Isbister GK, Gray MR. White-tail spider bite: a prospective study of 130 definite bites by Lampona species. Med J Aust 2003; in press.
- 14. GraphPad StatMate [computer program]. Version 1.0. San Diego: GraphPad Software, Inc, 1995.
- 15. GraphPad InStat [computer program]. Version 3.05 San Diego: GraphPad Software, Inc, 2000.
- 16. StatXact [computer program]. Version 4.0. Cambridge, Mass: Cytel Software Corporation, 1998.
- 17. Mead HJ, Jelinek GA. Red-back spider bites to Perth children, 1979–1988. J Paediatr Child Health 1993; 29: 305-308.
- 18. Fisher MM, Bowey CJ. Urban envenomation. Med J Aust 1989; 150: 695-698.
- 19. Sutherland SK, Trinca JC. Survey of 2144 cases of red-back spider bites: Australia and New Zealand, 1963–1976. Med J Aust 1978; 2: 620-623.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.